Zantac Lawsuit


Researching drug company and regulatory malfeasance for over 16 years
Humanist, humorist

Tuesday, February 12, 2008

Email to Australian Prime Minister Kevin Rudd

Name: Mr BOB FIDDAMAN
Email Address: REDACTED
Postal Address: REDACTED

Subject: Aropax & GlaxoSmithKline

Comment:

Dear Sir,

Firstly I would like to introduce myself. My name is Bob Fiddaman and I currently reside in Birmingham, UK.

For the past four years I have been an advocate in warning the public about the dangers of Paroxetine (Aropax in Australia)I have had much communication with the Medicines Healthcare products Regulatory Agency (MHRA) here in the UK regarding issues about the side effects and suicidal tendancies that this particular SSRi can cause.

To cut a very long story short, the MHRA know who I am through countless Freedom of Information requests to them and for highlighting correspondence on my blog SEROXAT SUFFERERS (http://fiddaman.blogspot.com)

As you are probably aware the recent European Directive, supported by the MHRA, has requested that suicide warnings be placed on ALL antidepressants in the UK. Strangely, this only applies to patients 25 years of age or under.

As you can clearly see in this document (http://media.newscientist.com/data/images/ns/av/mg19726424600D1.pdf) the suicide attempts not only occured in patients under the age of 25 - infact there were more suicide attempts from the age of 26 upwards. These seemed to occur within the first ten weeks of taking Seroxat (Aropax).

The pdf link is an analysis of internal GSK memos and reports, which were released to US lawyers seeking damages, and suggests that the company had trial data demonstrating an eightfold increase in suicide risk as early as 1989.

I feel the need to bring this to your attention for you to at least read through the documents and to arrive at a decision that may safeguard the health of Australian citizens.

A copy of this is also being sent to the TGA.

Basically, the documents will show you how GlaxoSmithKline have manipulated medicine regulators around the world with their "bad numbers". They have known since 1989 that Seroxat (Aropax) had an 8 fold increase of patients taking it... patients of ALL ages.

I sincerely hope that you can give this your utmost attention. I know I am not a citizen of Australia but I have a passion for human life... as you will see through reading the 74 page document - GlaxoSmithKline do not!

Warm regards

Bob Fiddaman

ADDRESS REDACTED
UK
EMAIL: REDACTED

No comments:


Please contact me if you would like a guest post considered for publication on my blog.